News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

October

20

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Neurobehavioral Outcomes in a Model of Traumatic Brain Injury

Pre-clinical trial demonstrates ability of nVNS to decrease amount of brain injury, decrease anxiety...

19

electroCore, Inc. Announces the Establishment of a Unique Level II HCPCS Code for “Non-Invasive Vagus Nerve Stimulator”

Decision covering gammaCore Sapphire™ D will go into effect April 1, 2021 ROCKAWAY, N.J., Jan. 19,...

11

electroCore Provides Business Update and Select Financial Guidance

Full year 2020 revenue expected at the upper end of previously announced guidance range...

30

electroCore Appoints Medical Technology Veteran Daniel S. Goldberger as Chief Executive Officer

35-year biotechnology and medical technology veteran to lead bio-electric medicine company BASKING RIDGE, N.J., Sept....

Recent developments